- Visibility 138 Views
- Downloads 129 Downloads
- Permissions
- DOI 10.18231/j.ijmr.21822.1758363213
-
CrossMark
- Citation
Emergence of metronidazole and clindamycin resistance among anaerobic Bacteroides fragilis group - A study from South India
Background: Bacteroides fragilis is the most common pathogenic group among anaerobic pathogens, primarily causing infections such as deep visceral abscesses, brain abscesses, diabetic foot ulcers, etc. Recent studies have shown increasing resistance among these bacteria to common antibiotics like metronidazole and clindamycin, which are used for empirical treatment.
Aim and Objective: The study aimed to analyze and identify the common pathogenic species of the Bacteroides fragilis group isolated from clinical samples and to determine the drug resistance for clindamycin and metronidazole.
Materials and Methods: A total of 51 Bacteroides fragilis group isolates were obtained from samples received for anaerobic culture from January 2021 to December 2023.The samples were inoculated onto anaerobic blood agar and other essential media. Identification was done using MALDI-TOF MS. Antibiotic susceptibility was performed using E-strip method and interpreted according to CLSI 2023 breakpoints for clindamycin and metronidazole.
Results: Bacteroides fragilis was found to be the most prevalent among the Bacteroides fragilis group isolates, followed by B.ovatus. The cultures showed a high incidence of polymicrobial growth (80%, n=41), with Prevotella species (n=6) being the most frequent obligate anaerobe grown along with Bacteroides fragilis group, while Escherichia coli (n=15) was the most common facultative anaerobe. 11 out of 51 isolates showed resistance to metronidazole (21%), while 2 isolates were intermediate (3.9%) and the rest were sensitive. 23 out of 51 isolates (45%) were resistant to clindamycin, 1 was intermediate (1.9%), and 27 isolates were sensitive to clindamycin.
Conclusion: This study reiterates that Bacteroides fragilis subspp fragilis is the most common Bacteroides fragilis group and is known to cause various anaerobic infection. There is an emergence of drug resistance among them towards commonly used antibiotics like metronidazole and clindamycin.
References
- Wexler HM. Bacteroides: the good, the bad, and the nitty-gritty. Clin Microbiol Rev. 2007;20(4):593–621.
- Sakamoto M, Benno Y. Reclassification of Bacteroides distasonis, Bacteroides goldsteinii and Bacteroides merdae as Parabacteroides distasonis gen. nov., comb. nov., Parabacteroides goldsteinii comb. nov. and Parabacteroides merdae comb. nov. Int J Syst Evol Microbiol. 2006;56(Pt 7):1599–605.
- Hansen KCM, Schwensen SAF, Henriksen DP, Justesen US, Sydenham TV. Antimicrobial resistance in the Bacteroides fragilis group in faecal samples from patients receiving broad-spectrum antibiotics. Anaerobe. 2017;47:79–85.
- Nagy E. Anaerobic infections: update on treatment considerations. Drugs. 2010;70(7):841–58.
- Marik PE. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med. 2001;344(9):665–71.
- Brook I. The role of anaerobic bacteria in chronic suppurative otitis media in children: Implications for medical therapy. Anaerobe. 2008;14(6):297–300.
- Green RJ, Dafoe DC, Rajfin TA. Necrotizing Fasciitis. Chest. 1996;110(1):219–29.
- Citron DM, Goldstein EJC, Merriam CV, Lipsky BA, Abramson MA. Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents. J Clin Microbiol. 2007;45(9):2819–28.
- Jousimies-Somer H, Summanen P, Citron D. Wadsworth-KTL anaerobic bacteriology manual. Belmont (CA): Start Now Press;
- Garner O, Mochon A, Branda J, Burnham C-A, Bythrow M, Ferraro M, et al. Multi-centre evaluation of mass spectrometric identification of anaerobic bacteria using the VITEK® MS system. Clin Microbiol Infect. 2014;20(4):335–9.
- Shenoy P, Vishwanath S, Chawla K. Antimicrobial resistance profile and Nim gene detection among Bacteroides fragilis group isolates in a university hospital in South India. J Glob Infect Dis. 2019;11(2):59–62.
- Nagy E, Boyanova L, Justesen US. How to isolate, identify and determine antimicrobial susceptibility of anaerobic bacteria in routine laboratories. Clin Microbiol Infect. 2018;24(11):1139–48.
- Yim J, Lee Y, Kim M, Seo YH, Kim WH, Yong D, et al. Antimicrobial susceptibility of clinical isolates of Bacteroides fragilis group organisms recovered from 2009 to 2012 in a Korean hospital. Ann Lab Med. 2015;35(1):94–8.
- Nagy E, Urbán E, Nord CE. Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience. Clin Microbiol Infect. 2011;17(3):371–9.
- Jahan L, Biswas R. Molecular study on metronidazole resistance in Bacteroides fragilis group isolates from a South Indian tertiary care center. Anaerobe. 2023;80:102692.
- CLSI. M100: Performance Standards for Antimicrobial Susceptability Testing; 2021.
- Karlowsky JA, Walkty AJ, Adam HJ, Baxter MR, Hoban DJ, Zhanel GG. Prevalence of antimicrobial resistance among clinical isolates of Bacteroides fragilis group in Canada in 2010-2011: CANWARD 400 Jacob and Gachinmath / Indian Journal of Microbiology Research 2025;12(3):394–400 surveillance study. Antimicrob Agents Chemother . 2011;56(3):1247–52.
- Byun JH, Kim MS, Lee Y, Lee K, Chong Y. Antimicrobial susceptibility patterns of anaerobic bacterial clinical isolates from 2014 to 2016, including recently named or renamed species. Ann Lab Med. 2019;39(2):190–9.
- Fernández-Canigia L, Litterio M, Legaria MC, Prior C, Rossetti M, Vay C. First national survey of antibiotic susceptibility of the Bacteroides fragilis group: emerging resistance to carbapenems in Argentina. Antimicrob Agents Chemother. 2012;56(3):1309–14.
- Tzianabos AO, Onderdonk AB, Rosner B, Cisneros RL, Kasper DL. Structural features of polysaccharides that induce intra-abdominal abscesses. Science. 1993;262(5132):416–9.
- Nakamura I, Aoki K, Miura Y, Yamaguchi T, Matsumoto T. Fatal sepsis caused by multidrug-resistant Bacteroides fragilis, harboring a cfiA gene and an upstream insertion sequence element, in Japan. Anaerobe. 2017;44:36–9.
- Elliott D, Kufera JA, Myers RAM. The microbiology of necrotizing soft tissue infections. Am J Surg. 2000;179(5):361–6.
- Shilnikova II, Dmitrieva NV. Evaluation of antibiotic susceptibility of Bacteroides, Prevotella and Fusobacterium species isolated from patients of the N. N. Blokhin Cancer Research Center, Moscow, Russia. Anaerobe. 2015;31:15–8.
- Sethi S, Shukla R, Bala K, Gautam V, Angrup A, Ray P. Emerging metronidazole resistance in Bacteroides spp. and its association with the nim gene: a study from North India. J Glob Antimicrob Resist. 2019;16:210–4.
- Buhl MEJ, Sunnerhagen T, Join-Lambert O, Morris T, Jeverica S, Assous MV, et al. Antimicrobial resistance surveillance of Bacteroides fragilis isolated from blood cultures, Europe, 2022 (ReSuBacfrag). Int J Antimicrob Agents. 2024;64(3):107241. Cite this article: Jacob S, Gachinmath S. Emergence of metronidazole and clindamycin resistance among anaerobic Bacteroides fragilis group - A study from South India. Indian J Microbiol Res. 2025;12(3):394–400.
How to Cite This Article
Vancouver
Jacob S, Gachinmath S. Emergence of metronidazole and clindamycin resistance among anaerobic <i>Bacteroides fragilis </i>group - A study from South India [Internet]. Indian J Microbiol Res. 2025 [cited 2025 Sep 29];12(3):394-400. Available from: https://doi.org/10.18231/j.ijmr.21822.1758363213
APA
Jacob, S., Gachinmath, S. (2025). Emergence of metronidazole and clindamycin resistance among anaerobic <i>Bacteroides fragilis </i>group - A study from South India. Indian J Microbiol Res, 12(3), 394-400. https://doi.org/10.18231/j.ijmr.21822.1758363213
MLA
Jacob, Sandra, Gachinmath, Supriya. "Emergence of metronidazole and clindamycin resistance among anaerobic <i>Bacteroides fragilis </i>group - A study from South India." Indian J Microbiol Res, vol. 12, no. 3, 2025, pp. 394-400. https://doi.org/10.18231/j.ijmr.21822.1758363213
Chicago
Jacob, S., Gachinmath, S.. "Emergence of metronidazole and clindamycin resistance among anaerobic <i>Bacteroides fragilis </i>group - A study from South India." Indian J Microbiol Res 12, no. 3 (2025): 394-400. https://doi.org/10.18231/j.ijmr.21822.1758363213